RecruitingNot ApplicableNCT06112509

Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery

Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife

Sponsor

Centre Hospitalier Universitaire de Besancon

Enrollment

20 participants

Start Date

Feb 20, 2024

Study Type

INTERVENTIONAL

Conditions

Vestibular Schwannoma Neurinoma, Acoustic Acoustic Neuroma

Summary

The purpose of this study is to evaluate the vestibular effects of gamma-knife radiosurgery, as part of the treatment of vestibular schwannoma.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria4

Men and women aged 18 to 90 included
Subject who benefited from gamma-knife radiosurgery as part of the treatment of vestibular schwannoma
Non-opposition of the subject to participate in the study
Affiliation to a French social security scheme or beneficiary of such a scheme

Exclusion Criteria6

Subject with another vestibular pathology
Subject who did not benefit from a vestibular assessment before treatment with gamma-knife radiosurgery
Legal incapacity or limited legal capacity
Subject unlikely to cooperate in the study and/or weak cooperation anticipated by the investigator
Subject without health insurance
Subject being in the period of exclusion from another study or provided for by the "national volunteer file".

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVestibular exam

Interrogation, videonystagmoscopy, videonystagmography, video-head-impulse-test

Locations(1)

CHU de Besançon

Besançon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06112509

Related Trials

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

NCT065178884 locations

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

NCT057027491 location